290 related articles for article (PubMed ID: 20647769)
1. Generation of antisera to purified prions in lipid rafts.
Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH
Prion; 2010; 4(2):94-104. PubMed ID: 20647769
[TBL] [Abstract][Full Text] [Related]
2. Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions.
Stanker LH; Scotcher MC; Lin A; McGarvey J; Prusiner SB; Hnasko R
Hybridoma (Larchmt); 2012 Oct; 31(5):314-24. PubMed ID: 23098297
[TBL] [Abstract][Full Text] [Related]
3. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
4. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
5. Packaging of prions into exosomes is associated with a novel pathway of PrP processing.
Vella LJ; Sharples RA; Lawson VA; Masters CL; Cappai R; Hill AF
J Pathol; 2007 Apr; 211(5):582-590. PubMed ID: 17334982
[TBL] [Abstract][Full Text] [Related]
6. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
7. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
[TBL] [Abstract][Full Text] [Related]
8. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
9. Isolation of soluble and insoluble PrP oligomers in the normal human brain.
Xiao X; Yuan J; Zou WQ
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23070047
[TBL] [Abstract][Full Text] [Related]
10. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
11. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
12. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
13. Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.
Nakaoke R; Sakaguchi S; Atarashi R; Nishida N; Arima K; Shigematsu K; Katamine S
Cell Mol Neurobiol; 2000 Dec; 20(6):717-30. PubMed ID: 11100979
[TBL] [Abstract][Full Text] [Related]
14. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.
D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD
PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933
[TBL] [Abstract][Full Text] [Related]
15. The role of lipid rafts in prion protein biology.
Lewis V; Hooper NM
Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
[TBL] [Abstract][Full Text] [Related]
16. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
[TBL] [Abstract][Full Text] [Related]
17. The prion protein and lipid rafts.
Taylor DR; Hooper NM
Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
[TBL] [Abstract][Full Text] [Related]
18. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
Shoup D; Priola SA
Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
[TBL] [Abstract][Full Text] [Related]
19. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.
Avrahami D; Dayan-Amouyal Y; Tal S; Mincberg M; Davis C; Abramsky O; Gabizon R
J Neurosci Res; 2008 Sep; 86(12):2753-62. PubMed ID: 18478553
[TBL] [Abstract][Full Text] [Related]
20. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]